BlackRock Advisors’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

BlackRock Advisors’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$353K	Sell	511,878 -51,018	-9%	-$60.8K	﹤0.01%	2418
2016 Q3	$799K	Sell	562,896 -9,800	-2%	-$15.2K	﹤0.01%	1936
2016 Q2	$933K	Sell	572,696 -3,100	-0.5%	-$5.7K	﹤0.01%	1786
2016 Q1	$1.23M	Buy	575,796 +14,947	+3%	+$41.3K	﹤0.01%	1641
2015 Q4	$2.18M	Sell	560,849 -8,100	-1%	-$30.8K	﹤0.01%	1381
2015 Q3	$1.96M	Buy	568,949 +25,472	+5%	+$108K	﹤0.01%	1373
2015 Q2	$2.69M	Buy	543,477 +1,681	+0.3%	+$7.42K	﹤0.01%	1162
2015 Q1	$2.66M	Hold	541,796	–	–	﹤0.01%	1123
2014 Q4	$2.25M	Sell	541,796 -5,753	-1%	-$26.1K	﹤0.01%	1165
2014 Q3	$3.15M	Buy	+547,549	New	+$3.3M	﹤0.01%	1062

Other funds holding PARN

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Advisors's PARN Position: Q4 2016 in Review

BlackRock Advisors reduced its Parnell Pharmaceuticals Holdings Ltd (PARN) stake by 9.1% in Q4 2016, selling an estimated $60.8K and leaving 511,878 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

BlackRock Advisors first reported a position in PARN in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.15M in Q3 2014. 20 funds tracked by Wall St. Rank hold PARN as of Q4 2016.

BlackRock Advisors held 511,878 shares of Parnell Pharmaceuticals Holdings Ltd worth $353K as of Q4 2016.
BlackRock Advisors sold 51,018 Parnell Pharmaceuticals Holdings Ltd shares in Q4 2016, an estimated $60.8K.
Parnell Pharmaceuticals Holdings Ltd made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2418 holding.
BlackRock Advisors first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and has held it in 10 quarters since.
BlackRock Advisors's Parnell Pharmaceuticals Holdings Ltd position peaked at $3.15M in Q3 2014.
20 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.